LAM-561 with radiotherapy and temozolomide for treating IDH1 wild-type glioblastoma [ID4022]

  • Awaiting development
  • GID-TA11741
  • Expected publication date: TBC
To appraise the clinical and cost effectiveness of LAM561 + temozolomide + radiotherapy within its marketing authorisation for treating glioma